Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42).

Lee KH, Shin BH, Shin KJ, Kim DJ, Yu J.

Biochem Biophys Res Commun. 2005 Mar 25;328(4):816-23.

PMID:
15707952
2.

Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.

Schuster D, Rajendran A, Hui SW, Nicotera T, Srikrishnan T, Kruzel ML.

Neuropeptides. 2005 Aug;39(4):419-26.

PMID:
15890402
3.

Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.

Taylor M, Moore S, Mayes J, Parkin E, Beeg M, Canovi M, Gobbi M, Mann DM, Allsop D.

Biochemistry. 2010 Apr 20;49(15):3261-72. doi: 10.1021/bi100144m.

PMID:
20230062
4.

Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.

Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL.

Protein Eng Des Sel. 2009 Mar;22(3):199-208. doi: 10.1093/protein/gzn052. Epub 2008 Oct 16.

PMID:
18927231
5.

Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.

Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H.

J Neurochem. 2002 May;81(3):434-40.

6.

Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.

Kanapathipillai M, Lentzen G, Sierks M, Park CB.

FEBS Lett. 2005 Aug 29;579(21):4775-80.

7.

Mulberry leaf extract prevents amyloid beta-peptide fibril formation and neurotoxicity.

Niidome T, Takahashi K, Goto Y, Goh S, Tanaka N, Kamei K, Ichida M, Hara S, Akaike A, Kihara T, Sugimoto H.

Neuroreport. 2007 May 28;18(8):813-6.

PMID:
17471072
8.

Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.

Austen BM, Paleologou KE, Ali SA, Qureshi MM, Allsop D, El-Agnaf OM.

Biochemistry. 2008 Feb 19;47(7):1984-92. doi: 10.1021/bi701415b. Epub 2008 Jan 12.

PMID:
18189413
9.

Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.

Takahashi T, Mihara H.

Acc Chem Res. 2008 Oct;41(10):1309-18. doi: 10.1021/ar8000475.

PMID:
18937396
10.

A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro.

Nakagami Y, Nishimura S, Murasugi T, Kaneko I, Meguro M, Marumoto S, Kogen H, Koyama K, Oda T.

Br J Pharmacol. 2002 Nov;137(5):676-82.

11.

Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.

Liu R, Yuan B, Emadi S, Zameer A, Schulz P, McAllister C, Lyubchenko Y, Goud G, Sierks MR.

Biochemistry. 2004 Jun 8;43(22):6959-67.

PMID:
15170333
12.

A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes.

Maezawa I, Hong HS, Wu HC, Battina SK, Rana S, Iwamoto T, Radke GA, Pettersson E, Martin GM, Hua DH, Jin LW.

J Neurochem. 2006 Jul;98(1):57-67.

13.

l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells.

Peng Y, Xing C, Lemere CA, Chen G, Wang L, Feng Y, Wang X.

Neurosci Lett. 2008 Mar 28;434(2):224-9. doi: 10.1016/j.neulet.2008.01.080. Epub 2008 Feb 14.

PMID:
18328624
14.

A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.

Dolphin GT, Chierici S, Ouberai M, Dumy P, Garcia J.

Chembiochem. 2008 Apr 14;9(6):952-63. doi: 10.1002/cbic.200700602.

PMID:
18330854
15.

Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons.

Kimura M, Komatsu H, Ogura H, Sawada K.

Neurosci Lett. 2005 Dec 31;391(1-2):17-21. Epub 2005 Sep 8.

PMID:
16154269
16.

Surface structure of amyloid-beta fibrils contributes to cytotoxicity.

Yoshiike Y, Akagi T, Takashima A.

Biochemistry. 2007 Aug 28;46(34):9805-12. Epub 2007 Aug 4.

PMID:
17676931
17.

Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.

Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, Abe K.

Neurosci Lett. 2008 Oct 31;444(3):280-5. doi: 10.1016/j.neulet.2008.08.052. Epub 2008 Aug 22.

PMID:
18761054
18.

Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.

Cui L, Zhang Y, Cao H, Wang Y, Teng T, Ma G, Li Y, Li K, Zhang Y.

J Alzheimers Dis. 2013;37(1):19-28. doi: 10.3233/JAD-130164.

PMID:
23727899
19.

Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.

Okada T, Wakabayashi M, Ikeda K, Matsuzaki K.

J Mol Biol. 2007 Aug 10;371(2):481-9. Epub 2007 May 31.

PMID:
17582434
20.

Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.

Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O.

J Neurochem. 2008 Dec;107(6):1634-46. doi: 10.1111/j.1471-4159.2008.05731.x. Epub 2008 Nov 5.

Supplemental Content

Support Center